Page History

...

Alcohol usage and tobacco product usage were represented in the SU domain. SUCAT allows the records to be grouped into tobacco-related data and alcohol related data. In this example, the products were prespecified so SUTRT does not require a standardized SUDECOD equivalent. The sponsor applicant only includes SUSTDTC and SUENDTC as timing variables.   

Drugs used to treat nicotine dependency are considered drugs and were represented in the Concomitant Medication (CM) domain. This subject used a 14 mg nicotine replacement patch. The sponsor applicant included the CMCLASS, CMDECOD, and CMMODIFY. These were included to reflect standardized coding of the medication.  

...

A Product Accountability (DA) domain was used to represent the amount of study product transferred to or from the study subjects. At each visit, each subject was supplied with 90 cartridges per week for weeks 1-3, and 50 cartridges per week for weeks 4-6. The number of cartridges returned were counted. DACAT was used to indicate that the product of interest was the study product. DASPID and DAREFID can be used for code numbers that appeared on the study product label, in this case no code numbers were included on the labels. The sponsor applicant included VISITNUM and DADTC as these variables are expected in this domain. DADTC was the date the supplies were dispensed or returned, these corresponded to the dates of the visits.   

The sponsor applicant used a patient diary (not shown here) to determine how many cartridges the subject used on each day, then created the EC data shown below to represent the collected exposure data. The usage recommendations were represented in ECDOSRGM, which is the intended Dose Regimen. The ECMOOD permissible variable was used to reflect the prescribed and the actual usage of the inhaled nicotine. When this variable is used, it must be populated for all records. This variable cannot be used in EX.   

...

The EX dataset shows the actual administrations. Note the scheduled records are not included. Only a few rows are shown for illustration. The pharmaceutical strength was included to identify the dose of the nicotine inhaler used by the subject. Since EXENDTC is an expected variable, the sponsor applicant populated this timing variable with the start date.    

...